Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-04

Clinical Trial Update: Tofacitinib For Treatment Of Chronic Pouchitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tofacitinib for chronic pouchitis has been terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Pouchitis, Ileal Pouchitis | Phase 2 | Status: TERMINATED | Results posted: 2024-04-04